Addendum 2 Most Commonly Used Tests - VA TAT Thresholds.xlsx
XLSX spreadsheet 14 KB Posted
- Attached to
- Q301--Referral Lab Services - VISN 15
- Solicitation number
- 36C25521R0004
About this file
This document contains details on a forthcoming solicitation from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 for referral laboratory services. The solicitation seeks proposals for an Indefinite Delivery Requirements Contract to provide pre-analytic processing, analysis, and result interpretation for clinical and anatomical pathology specimens. Interested parties should monitor the Contract Opportunities website for issuance of solicitation number 36C25521R0004 on or around December 1, 2020. The solicitation will require registration in the System for Award Management and VetBiz database for applicable small businesses. The NAICS code is 621511 for medical laboratories with a small business size standard of $35 million. Proposals will be accepted on an unrestricted basis. The point of contact is Paula Galvin at paula.galvin@va.gov.
View the file
Other files
Show all 23
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Top Tests-TAT VA's Turnaround Time Standard Threshhold
| Test Name | VA-- TAT's (in days) |
| ACTH, Plasma | 2 |
| Actin Antibody (IgG) | 5 |
| AFB Cult & Smear:Prog TB/MAI Probes,ID,Sens to All | 64 |
| Aldolase | 4 |
| Aldosterone, LC/MS/MS | 5 |
| Alpha-Fetoprotein, Tumor Marker | 2 |
| ANA Scr,IFA w/Refl Titer/Pattern/MPX Ab Cascade | 4 |
| ANA Screen, IFA, w/Refl Titer and Pattern | 5 |
| ANA, Titer and Pattern | 5 |
| ANCA Screen w/MPO and PR3, w/rflx to ANCA titer | 5 |
| B2 Microglobulin, Serum | 3 |
| BCR - ABL1 Gene Rearrangement, Quantitative PCR | 5 |
| CA 19-9 | 5 |
| Calprotectin, Stool | 4 |
| Celiac Disease Comprehensive Panel | 4 |
| Celiac Disease Panel (without Gliadin) [17612X] | 6 |
| Ceruloplasmin | 3 |
| Chlamydia/N. Gonorrhoeae RNA, TMA, Urogenital | 4 |
| Chromogranin A | 7 |
| Copper, Blood [35378X] | 5 |
| C-Peptide | 3 |
| CULTURE, AEROBIC BACTERIA WITH GRAM STAIN | 7 |
| CULTURE, BLOOD | 7 |
| CULTURE, URINE, ROUTINE | 3 |
| CULTURE, URINE, ROUTINE | 3 |
| Cyclic Citrullinated Peptide (CCP) Antibody IgG | 4 |
| Drug Monitor, Methamphetamine D/L, U | 3 |
| Drug Monitor, Opiates Expanded, Qn, Urine | 3 |
| Drug Monitor,Amphetamine, W/DL, QN Urine | 5 |
| Drug Test, General Toxicology, Urine | 4 |
| Ehrlichia chaffeensis Antibodies (IgG,IgM) | 4 |
| EHSCR | 1 |
| Erythropoietin (EPO) | 2 |
| Estradiol | 3 |
| Estradiol, Ultrasensitive, LC/MS | 3 |
| Fecal Fat, Qualitative | 4 |
| Folic Acid, Red Blood Cell | 5 |
| Fructosamine | 4 |
| Glutamic Acid Decarboxylase-65 Antibody | 2 |
| Helicobacter pylori Antigen, EIA, Stool | 2 |
| Hemoglobin A1c | 3 |
| Hepatitis A Ab, Total | 3 |
| Hepatitis A IgM | 3 |
| Hepatitis B Core Ab (IgM) | 3 |
| Hepatitis B Core Ab, Total | 3 |
| Hepatitis B Surface Antibody Immunity, (Quant) | 3 |
| Hepatitis B Surface Antigen w/Rflx to Confirm. | 3 |
| Hepatitis B Virus DNA, Quantitative, Real-Time PCR | 3 |
| Hepatitis C Viral RNA, Genotype, LiPA(R) | 5 |
| HEPATITIS C, RNA, QUANTITATIVE, PCR | 3 |
| Hereditary Hemochromatosis DNA Mutation Analysis [35079X] | 5 |
| Herpes Simplex Virus 1/2 (IgG), Type-Specific Ab | 4 |
| Histopathology Tissue/Biopsy [19459X] | 7 |
| HIV-1 RNA, Quantitative, Real-Time PCR | 3 |
| Homocysteine | 3 |
| HPV mRNA E6/E7 | 5 |
| Immunofixation, Serum | 5 |
| Immunoglobulin E | 3 |
| Iron and Total Iron Binding Capacity | 2 |
| JAK2 V617F Cascade refl CALR,JAK2 Exon12,MPL,CSF3R | 5 |
| Kappa/Lambda Light Chains, Free with Ratio, Serum [11234X] | 4 |
| Legionella Culture, Environmental [37357X] | 15 |
| Levetiracetam | 3 |
| LH | 2 |
| Lupus Anticoagulant Evaluation with Reflex | 4 |
| Lyme Disease Antibody with Rflx to Blot (IgG, IgM) | 4 |
| Lymphocyte Subset Panel 4 | 4 |
| Lymphocyte Subset Panel 4 [7924X] | 4 |
| Marijuana Metabolite, Quantitative, Urine [26514X] | 3 |
| Measles Antibody (IgG) | 4 |
| Methylmalonic Acid | 5 |
| Mitochondrial Antibody w/reflex to Titer | 4 |
| Mumps Virus Antibody (IgG) | 4 |
| Ova and Parasites, Concentrate and Permanent Smear [681X] | 7 |
| P210 BCR-ABL1 | 5 |
| Plasma Renin Activity, LC/MS/MS | 3 |
| Prolactin | 2 |
| Protein Total and Protein Electrophoresis, Urine | 5 |
| Protein, Total and Protein Electrophoresis | 5 |
| PSA, Free and Total | 2 |
| QUANTIFERON(R)-TB GOLD PLUS, 1 TUBE | 5 |
| Quantiferon(R)-TB Gold Plus, 4T, Incubated | 5 |
| Respiratory Allergy Profile Region VIII [10649X] | 7 |
| Rheumatoid Factor | 3 |
| RICKETTSIA (RMSF) IGG,IGM W/REFL TO TITERS | 4 |
| RPR (DX) w/refl Titer and Confirmatory Testing | 2 |
| Rubella Antibody (IgG) | 4 |
| Scl-70 Antibody | 6 |
| Stone Analysis [30260X] | 7 |
| Streptococcus pneumoniae Antigens, Urine [16786X] | 2 |
| T3, Free | 2 |
| T3, Total | 2 |
| T4 (Thyroxine), Total | 2 |
| Tacrolimus, Highly Sensitive, LC/MS/MS | 2 |
| Testosterone, Free, Bio and Total, MS | 5 |
| Testosterone, Total, MS | 5 |
| Thyroglobulin Antibodies | 2 |
| Thyroglobulin Panel | 2 |
| Thyroid Peroxidase Antibodies | 3 |
| Tramadol (Ultram), Confirmation by GCMS, Urine [70120X] | 5 |
| Transferrin | 2 |
| Trichomonas vaginalis RNA, Qualitative TMA, Males | 3 |
| TSI(Thyroid Stimulating Immunoglobulin) | 2 |
| Varicella-Zoster Virus Antibody (IgG) | 4 |
| Vitamin B1 (Thiamine), B | 5 |
| Vitamin B1, S/P | 5 |
| Zinc | 2 |
File details come from the government source that posted it. Updated .